home / stock / vrtx / vrtx quote
Last: | $473.78 |
---|---|
Change Percent: | 0.32% |
Open: | $469.76 |
Close: | $473.78 |
High: | $477.93 |
Low: | $467.41 |
Volume: | 777,954 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$473.78 | $469.76 | $473.78 | $477.93 | $467.41 | 777,954 | 07-02-2024 |
$471.25 | $467.94 | $471.25 | $478.96 | $467.855 | 950,626 | 07-01-2024 |
$468.72 | $473.21 | $468.72 | $477.31 | $467.67 | 3,234,634 | 06-28-2024 |
$472.51 | $476.77 | $472.51 | $477.84 | $472.11 | 959,734 | 06-27-2024 |
$474 | $471.72 | $474 | $481.14 | $469.945 | 1,272,331 | 06-26-2024 |
$473.82 | $478.3 | $473.82 | $483.9222 | $471.3101 | 1,195,842 | 06-25-2024 |
$474.95 | $472.72 | $474.95 | $477.555 | $468.12 | 1,188,598 | 06-24-2024 |
$468.71 | $464.39 | $468.71 | $472.56 | $464.39 | 2,825,832 | 06-21-2024 |
$471.38 | $466.18 | $471.38 | $473.28 | $463.23 | 1,409,844 | 06-20-2024 |
$467.28 | $473.4 | $467.28 | $476.37 | $466.51 | 1,230,804 | 06-19-2024 |
$467.28 | $473.4 | $467.28 | $476.37 | $466.51 | 1,230,804 | 06-18-2024 |
$473.69 | $479.13 | $473.69 | $479.15 | $473.11 | 1,190,217 | 06-17-2024 |
$480.73 | $477.73 | $480.73 | $483.53 | $477.73 | 641,768 | 06-14-2024 |
$479.03 | $473.5 | $479.03 | $481.35 | $472.61 | 808,498 | 06-13-2024 |
$475.79 | $478 | $475.79 | $481.71 | $473.505 | 1,245,007 | 06-12-2024 |
$481.53 | $481.82 | $481.53 | $483.23 | $478.38 | 882,034 | 06-11-2024 |
$483.28 | $480.18 | $483.28 | $485.4 | $478.51 | 1,253,805 | 06-10-2024 |
$483.04 | $484.45 | $483.04 | $486.425 | $480.1022 | 944,440 | 06-07-2024 |
$485.53 | $484.41 | $485.53 | $485.85 | $479.02 | 1,263,810 | 06-06-2024 |
$483.04 | $475.26 | $483.04 | $484.45 | $474.16 | 1,196,706 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Vertex Pharmaceuticals Incorporated Company Name:
VRTX Stock Symbol:
NASDAQ Market:
Vertex Pharmaceuticals Incorporated Website:
- Vanza triple granted priority review with Prescription Drug User Fee Act (PDUFA) target action date of January 2, 2025 – - EU Marketing Authorization Application (MAA) submission also validated by European Medicines Agency (EMA) Vertex Pharmaceuticals Incorporated (...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2024 financial results on Thursday, August 1, 2024 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +...
2024-06-28 07:45:00 ET The stock market has its ups and downs -- and if you stay invested for decades, you will likely experience your fair share of both bull and bear markets. At the same time, by investing in a diverse assortment of stocks across various industries, risk profiles, and bus...